2023
Wadenpohl T, Shein M, Steinberg J, Lehmann J B, Schütz AK, Jung S: ”Economical large-scale purification of extracellular vesicles from urine”, Separation and Purification Technology (Elsevir), in revision and published ahead of print
2022
Walter A J, van de Klundert M*, Jung S*: Many ways to communicate – crosstalk between the HBV infected cell and its environment, Pathogens 12(1):29
Nicolai M, Steinberg J, Obermann H-L, Venegas Solis F, Bartok E, Bauer S, Jung S (2022)Identification of an optimal TLR8 ligand by alternating the position of 2′-O-ribose methylation, IJMS 23(19):11139
2021
Altstetter, S.M., Quitt, O., Pinci, F., Hornung, V., Lucko, A.M., Wisskirchen, K., Jung, S.*, Protzer, U.*: Hepatitis-D Virus infection is resistent to innate immune response but increases cytotoxic T-cell activity, Cells 10(11):3253
Steinberg J, Wadenpohl T, Jung S: The Endogenous RIG-I Ligand Is Generated in Influenza A-Virus Infected Cells, Viruses 13(8):1564
2020
Jung S, Jacobs KFK, Shein M, Schütz AK, Mohr F, Stadler H, Lucko AM, Altstetter SM, Wilsch F, Protzer U: Efficient and reproducible depletion of Hepatitis B virus from plasma derived extracellular vesicles, Journal of extracellular vesicles (2):e12040
Jung, S., von Thülen, T., Yang, I., Laukemper, V., Rupf, B., Janga, H., Panagiotidis, G., Schön, A., Nicolai, M., Schulte, L., Obermann, H-L., Weber, F., Kaufmann, A., Bauer, S. (2020) A Ribosmal RNA fragment with 2’,3’-cyclic phosphate and GTP- binding activity acts as RIG-I ligand, Nucleic Acid Research, Vol. 48, No. 18 10397–10412
Jung, S., Altstetter, S.M., Protzer, U. (2020), Innate Immune Recognition and Modulation in Hepatitis Delta Virus Infection, World Journal of Gastroenterology, 26(21): 2781-2791
Jung, S., Altstetter, S.M., Wilsch, F., Shein, M., Schütz, A.K., Protzer, U. (2020), Extracellular vesicles derived from Hepatitis-D Virus infected cells induce a proinflammatory cytokine response in human peripheral blood mononuclear cells and macrophages, Matters, https://sciencematters.io/articles/202002000001
2019
Théry, C., Witwer, K.W. [and 379 others, including S Jung] (2019) Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines, Journal of extracellular vesicles, 7(1):1535750
Roggendorf, M., Karimzadeh, H., Jung, S., Neumann-Haefelin, C. (2019), New developments for prophylactic and therapeutic vaccines against HDV, Hepatitis D. Virology, management and methodology16: 279-294
2015
Jung, S., von Thülen, T., Laukemper, V., Pigisch, S., Hangel, D., Hamm, S., Wagner, H., Kaufmann, A., Bauer, S. (2015), A single naturally occurring 2’-O-methylation converts a TLR7 and TLR8 activating RNA into a TLR8 specific ligand, PLoS One 10(3): e0120498.
2010
Hoenen, T., Biedenkopf, N., Zielecki, F., Jung, S., Groseth, A., Feldmann, H., Becker, S. (2010), Oligomerization of Ebola virus VP40 is essential for particle morphogenesis and regulation of viral transcription, Journal of Virology 84:7053-63
Hoenen, T., Jung, S., Herwig, A., Groseth, A., Becker, S. (2010), Both matrix proteins of Ebola virus contribute to the regulation of viral genome replication and transcription, Virology 403:56-66
2009
Winter, J.*, Jung, S.*, Keller, S., Gregory, R.I., Diederichs, S. (2009), Many roads to maturity: microRNA biogenesis pathways and their regulation, Nature Cell Biology 11: 228-234
2008
Diederichs, S., Jung, S., Rothenberg, S.M., Smolen, G.A., Mlody, B.G., Haber, D.A. (2008), Co-expression of Argonaute-2 enhances RNA Interference towards perfect match binding sites, PNAS, 105: 9284-9289
Asterisks (*) indicate equal contributoin